Copyright Reports & Markets. All rights reserved.

Point-of-Care Molecular Diagnostics -Global Market Status and Trend Report 2013-2023

Request for Sample of this report
Buy now

Table of Contents

    Chapter 1 Overview of Point-of-Care Molecular Diagnostics

    • 1.1 Definition of Point-of-Care Molecular Diagnostics in This Report
    • 1.2 Commercial Types of Point-of-Care Molecular Diagnostics
      • 1.2.1 PCR-based
      • 1.2.2 Genetic Sequencing-based
      • 1.2.3 Hybridization-based
      • 1.2.4 Microarray-based
    • 1.3 Downstream Application of Point-of-Care Molecular Diagnostics
      • 1.3.1 Infectious Diseases
      • 1.3.2 Oncology
      • 1.3.3 Hematology
      • 1.3.4 Prenatal Testing
      • 1.3.5 Endocrinology
      • 1.3.6 Other
    • 1.4 Development History of Point-of-Care Molecular Diagnostics
    • 1.5 Market Status and Trend of Point-of-Care Molecular Diagnostics 2013-2023
      • 1.5.1 Global Point-of-Care Molecular Diagnostics Market Status and Trend 2013-2023
      • 1.5.2 Regional Point-of-Care Molecular Diagnostics Market Status and Trend 2013-2023

    Chapter 2 Global Market Status and Forecast by Regions

    • 2.1 Market Development of Point-of-Care Molecular Diagnostics 2013-2017
    • 2.2 Production Market of Point-of-Care Molecular Diagnostics by Regions
      • 2.2.1 Production Volume of Point-of-Care Molecular Diagnostics by Regions
      • 2.2.2 Production Value of Point-of-Care Molecular Diagnostics by Regions
    • 2.3 Demand Market of Point-of-Care Molecular Diagnostics by Regions
    • 2.4 Production and Demand Status of Point-of-Care Molecular Diagnostics by Regions
      • 2.4.1 Production and Demand Status of Point-of-Care Molecular Diagnostics by Regions 2013-2017
      • 2.4.2 Import and Export Status of Point-of-Care Molecular Diagnostics by Regions 2013-2017

    Chapter 3 Global Market Status and Forecast by Types

    • 3.1 Production Volume of Point-of-Care Molecular Diagnostics by Types
    • 3.2 Production Value of Point-of-Care Molecular Diagnostics by Types
    • 3.3 Market Forecast of Point-of-Care Molecular Diagnostics by Types

    Chapter 4 Global Market Status and Forecast by Downstream Industry

    • 4.1 Demand Volume of Point-of-Care Molecular Diagnostics by Downstream Industry
    • 4.2 Market Forecast of Point-of-Care Molecular Diagnostics by Downstream Industry

    Chapter 5 Market Driving Factor Analysis of Point-of-Care Molecular Diagnostics

    • 5.1 Global Economy Situation and Trend Overview
    • 5.2 Point-of-Care Molecular Diagnostics Downstream Industry Situation and Trend Overview

    Chapter 6 Point-of-Care Molecular Diagnostics Market Competition Status by Major Manufacturers

    • 6.1 Production Volume of Point-of-Care Molecular Diagnostics by Major Manufacturers
    • 6.2 Production Value of Point-of-Care Molecular Diagnostics by Major Manufacturers
    • 6.3 Basic Information of Point-of-Care Molecular Diagnostics by Major Manufacturers
      • 6.3.1 Headquarters Location and Established Time of Point-of-Care Molecular Diagnostics Major Manufacturer
      • 6.3.2 Employees and Revenue Level of Point-of-Care Molecular Diagnostics Major Manufacturer
    • 6.4 Market Competition News and Trend
      • 6.4.1 Merger, Consolidation or Acquisition News
      • 6.4.2 Investment or Disinvestment News
      • 6.4.3 New Product Development and Launch

    Chapter 7 Point-of-Care Molecular Diagnostics Major Manufacturers Introduction and Market Data

    • 7.1 Danaher Corporation
      • 7.1.1 Company profile
      • 7.1.2 Representative Point-of-Care Molecular Diagnostics Product
      • 7.1.3 Point-of-Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Danaher Corporation
    • 7.2 Johnson and Johnson
      • 7.2.1 Company profile
      • 7.2.2 Representative Point-of-Care Molecular Diagnostics Product
      • 7.2.3 Point-of-Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Johnson and Johnson
    • 7.3 BioMerieux
      • 7.3.1 Company profile
      • 7.3.2 Representative Point-of-Care Molecular Diagnostics Product
      • 7.3.3 Point-of-Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of BioMerieux
    • 7.4 F. Hoffmann-La Roche AG
      • 7.4.1 Company profile
      • 7.4.2 Representative Point-of-Care Molecular Diagnostics Product
      • 7.4.3 Point-of-Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche AG
    • 7.5 Abbott Laboratories, Bayer Healthcare
      • 7.5.1 Company profile
      • 7.5.2 Representative Point-of-Care Molecular Diagnostics Product
      • 7.5.3 Point-of-Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories, Bayer Healthcare
    • 7.6 Becton, Dickinson and Company
      • 7.6.1 Company profile
      • 7.6.2 Representative Point-of-Care Molecular Diagnostics Product
      • 7.6.3 Point-of-Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson and Company
    • 7.7 Cepheid, Inc.
      • 7.7.1 Company profile
      • 7.7.2 Representative Point-of-Care Molecular Diagnostics Product
      • 7.7.3 Point-of-Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid, Inc.
    • 7.8 Bio-Rad Laboratories, Inc.
      • 7.8.1 Company profile
      • 7.8.2 Representative Point-of-Care Molecular Diagnostics Product
      • 7.8.3 Point-of-Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories, Inc.

    Chapter 8 Upstream and Downstream Market Analysis of Point-of-Care Molecular Diagnostics

    • 8.1 Industry Chain of Point-of-Care Molecular Diagnostics
    • 8.2 Upstream Market and Representative Companies Analysis
    • 8.3 Downstream Market and Representative Companies Analysis

    Chapter 9 Cost and Gross Margin Analysis of Point-of-Care Molecular Diagnostics

    • 9.1 Cost Structure Analysis of Point-of-Care Molecular Diagnostics
    • 9.2 Raw Materials Cost Analysis of Point-of-Care Molecular Diagnostics
    • 9.3 Labor Cost Analysis of Point-of-Care Molecular Diagnostics
    • 9.4 Manufacturing Expenses Analysis of Point-of-Care Molecular Diagnostics

    Chapter 10 Marketing Status Analysis of Point-of-Care Molecular Diagnostics

    • 10.1 Marketing Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
      • 10.1.3 Marketing Channel Development Trend
    • 10.2 Market Positioning
      • 10.2.1 Pricing Strategy
      • 10.2.2 Brand Strategy
      • 10.2.3 Target Client
    • 10.3 Distributors/Traders List

    Chapter 11 Report Conclusion

      Chapter 12 Research Methodology and Reference

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources

      Report Summary

      Point-of-Care Molecular Diagnostics -Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Point-of-Care Molecular Diagnostics  industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

      Worldwide and Regional Market Size of Point-of-Care Molecular Diagnostics  2013-2017, and development forecast 2018-2023
      Main manufacturers/suppliers of Point-of-Care Molecular Diagnostics  worldwide, with company and product introduction, position in the Point-of-Care Molecular Diagnostics  market
      Market status and development trend of Point-of-Care Molecular Diagnostics  by types and applications
      Cost and profit status of Point-of-Care Molecular Diagnostics , and marketing status
      Market growth drivers and challenges

      The report segments the global Point-of-Care Molecular Diagnostics  market as:

      Global Point-of-Care Molecular Diagnostics  Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
      North America
      Europe
      China
      Japan
      Rest APAC
      Latin America

      Global Point-of-Care Molecular Diagnostics  Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
      PCR-based
      Genetic Sequencing-based
      Hybridization-based
      Microarray-based

      Global Point-of-Care Molecular Diagnostics  Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
      Infectious Diseases
      Oncology
      Hematology
      Prenatal Testing
      Endocrinology
      Other

      Global Point-of-Care Molecular Diagnostics  Market: Manufacturers Segment Analysis (Company and Product introduction, Point-of-Care Molecular Diagnostics  Sales Volume, Revenue, Price and Gross Margin):
      Danaher Corporation
      Johnson and Johnson
      BioMerieux
      F. Hoffmann-La Roche AG
      Abbott Laboratories, Bayer Healthcare
      Becton, Dickinson and Company
      Cepheid, Inc.
      Bio-Rad Laboratories, Inc.

      In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
      Buy now